New molecules offer hope for treating HIV and cancer
05 August, 2011 by Tim DeanThe discovery of two molecules that block endocytosis opens up the possibility of selectively preventing viruses like HIV from infecting cells and for halting the growth of cancers.
Sydney and UK researchers gang up on malaria
22 July, 2011 by Tim DeanResearchers from Sydney and the UK are partnering to understand why malaria can be fatal to some but milder in others.
Combined therapy offers promise for aggressive breast cancers
19 July, 2011 by Staff WritersA combination of a new anti-cancer drug with conventional chemotherapy offers improved results for aggressive ‘triple negative’ breast cancers.
Roger Reddel named Outstanding Cancer Researcher of the Year
18 July, 2011 by Staff WritersThe NSW Premier’s Award for Outstanding Cancer Research was awarded to Professor Roger Reddel for his research on the ability of cancer cells to keep on proliferating without limits.
Universal malaria vaccine to enter human trials
11 July, 2011 by Tim DeanA malaria vaccine developed at Griffths University that aims to protect against all known strains of the parasite will enter clinical trials within the next 12 months.
The prize of decoding ovarian cancer
08 June, 2011 by Tim DeanVictorian researcher Dr Wen Qui received the Premier’s Award for Health and Medical Research for her work in understanding how ovarian cancers spread.
Feature: Seeking a miRacle
31 May, 2011 by Graeme O'NeillProfessor Peter Leedman's team at the Western Australian Medical Research Institute (WAIMR) has discovered a microRNA molecule with remarkable promise as a therapy for cancers of epithelial tissues.
Feature: Leukaemia CSI
18 May, 2011 by Fiona WylieHunting down the precancerous stem cells that might be responsible for leukaemia is no mean feat. But Matthew McCormack and his team are on the job.
Feature: Seeking the source of leukaemia
16 May, 2011 by Fiona WylieDr Matthew McCormack and his team are hunting down the precancerous stem cells that are responsible for leukaemia, opening up the possibility new treatments.
Feature: New ways to test an old idea
11 May, 2011 by Fiona WylieDr Mark Shackleton has made great strides in understanding how melanomas form and propagate.
Health and medical research weathers 2011 budget
11 May, 2011 by Tim DeanHealth and medical research spending was not cut as expected in the 2011 budget to the relief of many scientists.
Feature: Putting cancer to the test
09 May, 2011 by Fiona WylieDr Mark Shackleton has been testing three leading models of melanoma formation and propagation, on the hunt for better diagnostics and treatments.
Genetic cause of rare neurodegenerative disease uncovered
02 May, 2011 by Staff WritersResearchers in the US, UK and Australia have uncovered two mutations that are responsible for the rare neurodegenerative disease, hereditary sensory and autonomic neuropathy type 1.
Researchers link diabetes with Sjogren’s syndrome
22 April, 2011 by Tim DeanGarvan Institute scientists have found a particular subset of T helper cells link type 1 diabetes and the rare autoimmune disease Sjogren's syndrome, suggesting a common underlying cause.
New biomarkers help guide pancreatic cancer surgery
15 April, 2011 by Staff WritersTwo new biomarkers discovered by Garvan researchers can indicate the likely success of inherently risky pancreatic cancer surgery.
